申请人:Gilead Sciences, Inc.
公开号:US20140135492A1
公开(公告)日:2014-05-15
The present application includes a compound of Formula I or II:
or a pharmaceutically acceptable salt, solvate, and/or ester thereof, compositions containing such compounds, therapeutic methods that include the administration of such compounds, and therapeutic methods that include the administration of such compounds with at least one additional active agent.
本申请包括公式I或II的化合物:或其药学上可接受的盐,溶剂合物和/或酯,包含这些化合物的组合物,包括给予这些化合物的治疗方法,以及包括给予这些化合物和至少一种额外活性剂的治疗方法。